Anti-Ageing Drugs

Anti-Ageing Drugs Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report ID: BMRC 409 | Number of pages: 202 | Publish Date: Jul 2019 | Category: Lifesciences and Healthcare
Anti-Ageing Drugs Market was valued at USD XX Million in 2018 and expected to reach USD XX Million by 2025 with a CAGR of XX% during the forecast period. The growing influence of lifestyle industry coupled with high levels of disposable income are some of the key factors expected to spur the growth of Global Anti-Ageing Drugs Market.

Scope of Anti-Ageing Drugs Market Report:

The global anti-ageing drugs market is set to witness huge growth potential in the coming years owing to rising awareness among the aging population regarding the use of anti-aging products. The industry however is in its infancy stage due to lot of skepticism regarding the cellular understanding of ageing process. On the other hand, the industry is also witnessing a large amount of research and development activities with drug manufacturers showing an increased focus towards significantly decreasing the impact of ageing and ultimately increasing the lifespan. Various recent discoveries indicating the use of pharmacology to delay and possibly improve the aging process has spurred the interest of many manufacturers. Aging is a natural process in a human life. However, such discoveries should contribute in increasing the life span of older people as well as maintain their quality of life. The introduction of such anti ageing drugs will lead to the reduction of socio-economic burden in developed countries particularly. Citing this, research and development of anti ageing drugs is on forefront in the developed countries of North America and Europe. The global Anti-ageing Drugs Market is witnessing a huge surge in research activities of biotechnology companies towards development of drugs to extend normal human lifespan. For instance, Elevian, Inc. is actively conducting research focused on a protein called growth differentiating factor 11 (GDF11). This protein is found to improve brain function, exercise capacity and fasten muscle repair process when introduced in old mice. Moreover, Elysium Health, one of the prominent players in the anti-aging market space has introduced an over the counter nutritional supplement that intends to boost one’s NAD+ levels leading to enhance longevity genes. However, clinical benefit of this supplement is not yet proven. Increasing target population and growing influence of lifestyle industry are some of the pivotal factors boosting the market growth. The rising ageing population acts as target market for anti-ageing drugs driving the growth of this market. According to the World Health Organization (WHO), the proportion of global population over age of 60 years is predicted to double and reach 22% by 2050 from 12% in 2015. Moreover, the growing influence of lifestyle and fashion industry has led to an increased desire among the old to stay young and healthy. Apart from this, the elevating level of beauty standards has led to boost in demand for anti-ageing drugs among all age groups. Rising investments in research and development activities leading to incessant launch of new products is anticipated to be another pivotal Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Anti-Ageing Drugs Market. Key Benefits for Anti-Ageing Drugs Market Reports • Global market report covers in-depth historical and forecast analysis. • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. • Global market report helps to identify opportunities in market place. • Global market report covers extensive analysis of emerging trends and competitive landscape.

Anti-Ageing Drugs Market Segmentation:-

By Type: • Injectable • Oral • Topical By Drug Class: • Antioxidants and enzymes • Serums and supplements • Stem cells By Application: • Skin • Hair • Muscles • Age-related disorders • Others By Region • North America o U.S. o Canada o Mexico • Europe o UK o France o Germany o Russia o Rest of Europe • Asia-Pacific o China o South Korea o India o Japan o Rest of Asia-Pacific • LAMEA o Latin America o Middle East o Africa North America accounted for the largest share in Anti-Ageing Drugs Market Developed economies of U.S. and Canada are the largest revenue contributors to the global anti-ageing drugs market. This should be well justified by the high living standards, huge paying capacity and growing influence of fashion and lifestyle industry among the population. Moreover, the region houses developed infrastructure for carrying out progressive research activities aimed towards development of new anti-ageing products. These factors have collectively led to the expansion of anti-ageing drugs market in the region. Europe is set to witness similar trends as that of North America and grab the second position in the global anti-ageing drugs market. While the growing personal care industry coupled with increasing awareness regarding use of anti-ageing products in the emerging economies of China and India is expected to propel the Asia Pacific anti-ageing drugs market growth in the years to come. Anti-Ageing Drugs Market Key Players: • Galderma • Sanofi • Allergan • Daewoong Pharmaceutical • MMJ PhytoTech • Revitacare • Merz Pharma • SciVision Biotech • Canbex Therapeutics • Sun Pharmaceuticals • Others This comprehensive report will provide: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to exploit • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximize profitability for your company. Our Market Research Solution Provides You Answer to Below Mentioned Question: • Which are the driving factors responsible for the growth of market? • Which are the roadblock factors of this market? • What are the new opportunities, by which market will grow in coming years? • What are the trends of this market? • Which are main factors responsible for new product launch? • How big is the global & regional market in terms of revenue, sales and production? • How far will the market grow in forecast period in terms of revenue, sales and production? • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017? • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025? • Which region has more opportunities?
Interested in this report?
Get your sample now!
Table of Content

1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Anti-Ageing Drugs Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Anti-Ageing Drugs Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Anti-Ageing Drugs Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Anti-Ageing Drugs Market Overview: Quantitative Analysis
3.1. Global Anti-Ageing Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Anti-Ageing Drugs Market Revenue Market Share (%), 2014- 2025
3.3. Global Anti-Ageing Drugs Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Anti-Ageing Drugs Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Anti-Ageing Drugs Market Analysis: By Type
5. Chapter – Global Anti-Ageing Drugs Market Analysis: By Drug Class
6. Chapter – Global Anti-Ageing Drugs Market Analysis: By Application
7. Chapter - Global Anti-Ageing Drugs Market Analysis: By Manufacturer 
7.1. Global Anti-Ageing Drugs Market Revenue (USD Million), by Manufacturer, 2014 - 2025
7.2. Global Anti-Ageing Drugs Market Share (%), by Manufacturer, 2018
7.3. Global Anti-Ageing Drugs Market Sales (Number of Units), by Manufacturer, 2014 - 2025
7.4. Global Anti-Ageing Drugs Market Share (%), by Manufacturer, 2018
7.5. Global Anti-Ageing Drugs Market Price (USD/Unit), by Manufacturer, 2014 - 2025
7.6. Global Anti-Ageing Drugs Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
7.7. Merger & Acquisition
7.8. Collaborations and Partnership
7.9. New Product Launch
8. Chapter –Anti-Ageing Drugs Market: Regional Analysis
8.1. North America
8.1.1. North America Anti-Ageing Drugs Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
8.1.2. North America Anti-Ageing Drugs Market Revenue (USD Million) By Country, 2014 – 2025.
8.1.3. North America Anti-Ageing Drugs Revenue Market Share (%) By Country, 2014 – 2025.
8.1.4. North America Anti-Ageing Drugs Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.5. North America Anti-Ageing Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.6. North America Anti-Ageing Drugs Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
8.1.7. North America Anti-Ageing Drugs Market Sales (Number of Units) By Country, 2014 – 2025.
8.1.8. North America Anti-Ageing Drugs Sales Market Share (%) By Country, 2014 – 2025.
8.1.9. North America Anti-Ageing Drugs Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.10. North America Anti-Ageing Drugs Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Chapter - Company Profiles
9.1. Galderma
9.1.1. Overview
9.1.2. Financials
9.1.3. Product portfolio
9.1.4. Anti-Ageing Drugs Market Revenue (USD Million) and Market Share (%), 2014 - 2018
9.1.5. Anti-Ageing Drugs Sales Market Share (%), 2014 - 2018
9.1.6. Business strategy
9.1.7. Recent developments
9.2. Sanofi
9.3. Allergan
9.4. Daewoong Pharmaceutical
9.5. MMJ PhytoTech
9.6. Revitacare
9.7. Merz Pharma
9.8. SciVision Biotech
9.9. Canbex Therapeutics
9.10. Sun Pharmaceuticals
9.11. Nu Skin
9.12. L’ORÉAL
9.13. Elysium Health Inc.
9.14. BIOTIME, INC. 
9.15. Others
10. Chapter – Market Research and Findings